Coronavirus Update: $8bn International Fund For Vaccines Created
Leaders Call For Unity Amid Rising US and China Tensions
Plus: Eli Lilly extends its presence in COVID-19 research with an alliance with China's Junshi Biosciences.
You may also be interested in...
The agreement will give all EU member states the option to access the drug major's investigational COVID-19 vaccine dubbed AZD1222 "in an equitable manner at no profit during the pandemic."
Dozens of specially outfitted RVs will roll out to long-term care facilities in the US to test the prophylactic and symptom-reducing potential of the antibody Lilly is developing with AbCellera.
Sanofi CEO Hudson tries to reassure France on access, but notes that Europe does not currently have a program to assure a supply of a coronavirus vaccine as soon as safety and efficacy have been established.